EP3157928
Kristalform2-((4S)-6-(4-Klórófenýl)-1-Metýl-4H-Bensó[C]Ísoxasóló[4,5-E]Asepín-4-Ýl)Asetamíð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.6.2015EP published:
13.2.2019EP application number:
15733597.7
EP translation filed:
6.5.2019Grant published:
15.5.2019EPO information:
European Patent Register
Max expiry date:
17.6.2035Expiry date:
17.6.2026Next due date:
30.6.2026
Title:
CRYSTALLINE FORMS OF 2-((4S)-6-(4-CHLOROPHENYL)-1-METHYL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-YL)ACETAMIDE
Timeline
Today
18.6.2015EP application
13.2.2019EP Publication
6.5.2019Translation submitted
15.5.2019Registration published
17.6.2026Expires
Owner
Name:
Constellation Pharmaceuticals, Inc.Address:
215 First Street, Suite 200, 02142, Cambridge, MA, US
Inventor
Name:
HALL, Michael L.Address:
Albany, NY, US
Agent
Name:
Örn Þór slf.Address:
Klukkuvöllum 17, 221, Hafnarfirði,
Priority
Number:
201462014782 PDate:
20.6.2014Country:
US
Classification
Categories:
C07D 491/048, C07D 491/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 31.7.2019
Expires: 17.6.2020
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 2.6.2020
Expires: 17.6.2021
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 2.6.2021
Expires: 17.6.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 1.6.2022
Expires: 17.6.2023
Payer: Patice ehf.
Number: 9
Paid: 11.6.2023
Expires: 17.6.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 31.5.2024
Expires: 17.6.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 10.6.2025
Expires: 17.6.2026
Payer: Árnason Faktor ehf.